SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,821,474 | -58.7% | 88,507 | -5.6% | 0.00% | -50.0% |
| Q2 2023 | $4,406,667 | +10.5% | 93,719 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $3,988,088 | +10.2% | 95,045 | +0.2% | 0.00% | 0.0% |
| Q4 2022 | $3,618,913 | +1.1% | 94,885 | +3.8% | 0.00% | 0.0% |
| Q3 2022 | $3,580,000 | +25.3% | 91,395 | +3.3% | 0.00% | +33.3% |
| Q2 2022 | $2,857,000 | -12.6% | 88,446 | -10.4% | 0.00% | +50.0% |
| Q1 2022 | $3,269,000 | -15.0% | 98,766 | +9.3% | 0.00% | 0.0% |
| Q4 2021 | $3,845,000 | +0.5% | 90,372 | +4.7% | 0.00% | 0.0% |
| Q3 2021 | $3,824,000 | -16.1% | 86,298 | +7.5% | 0.00% | 0.0% |
| Q2 2021 | $4,559,000 | -12.7% | 80,265 | +15.1% | 0.00% | -33.3% |
| Q1 2021 | $5,221,000 | +83.3% | 69,749 | +111.9% | 0.00% | +50.0% |
| Q4 2020 | $2,848,000 | +173.6% | 32,916 | +93.3% | 0.00% | +100.0% |
| Q3 2020 | $1,041,000 | +1477.3% | 17,030 | +971.1% | 0.00% | – |
| Q2 2020 | $66,000 | +164.0% | 1,590 | +80.9% | 0.00% | – |
| Q1 2020 | $25,000 | -28.6% | 879 | +79.4% | 0.00% | – |
| Q4 2019 | $35,000 | -49.3% | 490 | 0.0% | 0.00% | – |
| Q3 2019 | $69,000 | – | 490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |